サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541630

デジタル治療市場レポート：用途、最終用途、地域別、2024～2032年

Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
デジタル治療市場レポート：用途、最終用途、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタル治療市場規模は2023年に60億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに268億米ドルに達し、2024～2032年の間に17.5％の成長率（CAGR）を示すと予測しています。デジタル行動モニタリング治療に対する需要の高まり、慢性疾患の有病率の増加、個人の健康とフィットネスに対する大衆の意識の高まりは、市場を牽引する重要な要因の一つです。

スマートフォンとタブレットの利用増加が市場成長を促進

スマートフォンやタブレット端末への依存度の高まりは、さまざまな医療アプリと相まって、デジタル治療市場の成長を促進しています。スマートフォンやタブレットベースの医療アプリには、投薬ミスの発生率の低下、予防医療の促進、より正確な人員配置など、数多くの利点があります。医療における個人用技術デバイスの利用の増加は、デジタル治療（DTx）治療の需要を喚起しています。DTxは、治療法の安全性と有効性に対する患者のアクセスを向上させ、さまざまな言語で情報を提示し、病気や治療法に関する関連情報を提供し、医師が患者をケアする能力を拡大しています。さらに、DTxは先進的なケア提供方法であり、自宅で簡単に実施することができ、従来の治療に伴うスティグマ（烙印）を排除することができます。

デジタル治療市場動向

市場構造、主要企業による市場シェア、主要企業のポジショニング、主要成功戦略、競合ダッシュボード、企業評価象限などの競合分析が網羅されています。また、主要企業の詳細プロファイルも掲載しています。市場構造は中程度に細分化されており、多数の世界的・地域的参入企業が存在しています。さらに、研究開発（R&D）の革新や合併・買収（M&A）の増加により、この市場の競合環境は激化しています。デジタル治療業界では、市場構造が細分化されていること、製品の差別化やスイッチングコストが低いことから、新規参入企業の数は緩やかです。また、mヘルス開発者の増加が新規参入業者の脅威を高めています。しかし、特許の要件と先端技術の高コスト、厳格な規制手続きにより、新規参入業者の脅威は減少しています。

デジタル治療とは？

デジタル治療（DTx）とは、医療上の障害や疾患を予防、管理、治療するための、高品質なソフトウェアプログラムによるエビデンス別の治療介入です。DTxはSoftware-as-a-medical device（SaMD）の一種であり、ソフトウェアによる介入によって患者に行動変容をもたらし、病態の治療を支援します。DTxは、単独で、あるいは治療の最適化のためにソフトウェアを利用して病気を治療する、急速に発展しつつある治療法の一種です。DTxは、2型糖尿病、うっ血性心不全、肥満、アルツハイマー病、認知症、喘息、薬剤乱用、注意欠陥多動性障害（ADHD）、高血圧、不安、うつ病など、さまざまな疾患や症状の予防と管理を支援します。DTxはまた、患者の服薬アドヒアランスを向上させ、医療専門家（HCP）が患者やビジネスをデジタル管理できるよう支援します。

COVID-19のインパクト

COVID-19パンデミックの到来は、医療業界にとっての分水嶺と言えます。医療提供のあり方を劇的に変化させるとともに、世界の医療緊急事態に適切に対処するための世界各国の政府の準備不足を露呈しました。第一線の医療従事者はCOVID-19患者の管理に携わったが、他の健康状態、特に慢性的な健康状態にある患者は、クリニックでの受診が延期されたり回避されたりして困難を経験しました。さらに、併存疾患、特に肥満、心臓合併症、糖尿病を持つ患者のCOVID-19の転帰は、そうでない患者よりも悪かったため、これらの患者はさらに用心するよう求められました。パンデミックはまた、うつ病、不安障害、離脱症状などの精神疾患ももたらし、その管理は対面診療の欠如のために困難でした。このような相互に関連した出来事により、医療提供者は、健康危機に対処するためのデジタルヘルスソリューションに注目するようになりました。COVID-19の大流行時には、デジタルヘルス技術の導入に関してポジティブな傾向が観察され、医療業務とサービス提供の効率と有効性が向上しました。パンデミックが始まった後、様々なセグメントでのDTx用途の採用が何倍にも加速しました。さらに、COVID-19のパンデミックは、患者エンゲージメントを変革し、医療全体のデータを統合することで、バーチャルケアや在宅ケア技術の採用を増加させました。

デジタル治療市場動向

現在、2型糖尿病患者の間では、病気を管理し、モノのインターネット（IoT）対応のインスリンポンプやその他の健康モニタリングシステムを使用できるようにするために、DTxに対する需要が高まっています。このことは、服薬アドヒアランスと健康的なライフスタイルの変化を保証するためのデジタル行動モニタリング治療に対する需要の増加とともに、市場の成長を支える重要な要因の1つとなっています。加えて、従来の治療と比較して、経過観察の必要性や再発を減らすためにDTxの利用が増加していることも、良好な市場展望をもたらしています。さらに、心臓病、脳卒中、がん、肥満、関節炎などの慢性疾患の有病率が増加しています。これは、個人の健康とフィットネスに対する大衆の意識の高まりと相まって、市場の成長を促進しています。さらに、医師が患者の服薬アドヒアランスを管理し、支払者、医療提供者、薬局などの利害関係者間でシームレスなデータ転送を可能にする統合ヘルスエコシステムを構築するためのDTxに対する需要の高まりが、市場の成長を後押ししています。

本レポートで扱う主要質問

  • 2023年の世界のデジタル治療市場の市場規模は？
  • 2024～2032年の世界のデジタル治療市場の予想成長率は？
  • 世界のデジタル治療市場を牽引する主要因は何か？
  • 世界のデジタル治療市場に対するCOVID-19の影響は？
  • 世界のデジタル治療市場の用途別内訳は？
  • デジタル治療市場の用途別内訳は？
  • デジタル治療市場の世界における主要地域は？
  • 世界のデジタル治療市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のデジタル治療市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用途別

  • 糖尿病
  • 肥満
  • 心血管疾患
  • 中枢神経疾患
  • 呼吸器疾患
  • 禁煙
  • その他

第7章 市場内訳：最終用途別

  • 患者
  • プロバイダー
  • 支払者
  • 雇用主
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 2Morrow Inc.
    • Canary Health Inc.
    • Click Therapeutics Inc.
    • Mango Health Inc.（TrialCard Incorporated）
    • Noom Health Inc.
    • Omada Health Inc.
    • Pear Therapeutics, Inc.
    • Propeller Health（ResMed）
    • Teladoc Health Inc.
    • Voluntis Inc.
    • WellDoc Inc.
図表

List of Figures

  • Figure 1: Global: Digital Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Digital Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Digital Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Digital Therapeutics Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Digital Therapeutics Market: Breakup by End Use (in %), 2023
  • Figure 6: Global: Digital Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Digital Therapeutics (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Digital Therapeutics (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Digital Therapeutics (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Digital Therapeutics (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Digital Therapeutics (CVD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Digital Therapeutics (CVD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Digital Therapeutics (CNS Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Digital Therapeutics (CNS Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Digital Therapeutics (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Digital Therapeutics (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Digital Therapeutics (Smoking Cessation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Digital Therapeutics (Smoking Cessation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Digital Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Digital Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Digital Therapeutics (Patients) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Digital Therapeutics (Patients) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Digital Therapeutics (Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Digital Therapeutics (Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Digital Therapeutics (Payers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Digital Therapeutics (Payers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Digital Therapeutics (Employers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Digital Therapeutics (Employers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Digital Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Digital Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Digital Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Digital Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Digital Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Digital Therapeutics Industry: SWOT Analysis
  • Figure 81: Global: Digital Therapeutics Industry: Value Chain Analysis
  • Figure 82: Global: Digital Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Digital Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Digital Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Digital Therapeutics Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 4: Global: Digital Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Digital Therapeutics Market: Competitive Structure
  • Table 6: Global: Digital Therapeutics Market: Key Players
目次
Product Code: SR112024A3889

The global digital therapeutics market size reached US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.8 Billion by 2032, exhibiting a growth rate (CAGR) of 17.5% during 2024-2032. The growing demand for digital behavior-monitoring treatment, increasing prevalence of chronic diseases, and rising awareness among the masses about personal health and fitness represent one of the key factors driving the market.

Increasing Usage of Smartphones and Tablets Propelling Market Growth

The rising reliance on smartphones and tablets, coupled with different healthcare apps, is propelling the growth of the digital therapeutics market. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. The increasing utilization of personal technological devices in healthcare is catalyzing the demand for digital therapeutics (DTx) treatments. DTx is enhancing patient access to the safety and effectiveness of treatments, presenting information in different languages, providing relevant information about diseases and treatments, and expanding the ability of physicians to care for patients. Furthermore, it is an advanced mode of care delivery, which can be easily implemented at home and eliminates any stigma associated with traditional therapies.

Digital Therapeutics Market Trends:

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of a large number of global and regional players. Moreover, the competitive environment in this market is intensifying due to the increasing number of research and development (R&D) innovations and mergers and acquisitions (M&A). The volume of new entrants is moderate in the digital therapeutics industry due to the fragmented market structure and low product differentiation and switching cost. In addition, the growing number of mhealth developers is contributing to the high threat of new entrants. However, the requirement of patents and high costs of advanced technologies along with stringent regulatory procedures, decreases the threat from new entrants.

What are Digital Therapeutics?

Digital therapeutics (DTx) is an evidence-based therapeutic intervention driven by high-quality software programs to prevent, manage, or treat a medical disorder or disease. It is a form of a software-as-a-medical device (SaMD) that relies on software interventions to bring about behavioral changes in patients and help treat their conditions. DTx is a fast-emerging class of therapies that utilizes software to treat disease as a standalone or for treatment optimization. It assists in preventing and managing a wide variety of diseases and conditions, such as type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, and several others. DTx also aids in improving patient medication adherence and supporting healthcare professionals (HCPs) to manage their patients and businesses digitally.

COVID-19 Impact:

The arrival of the COVID-19 pandemic can be described as a watershed moment for the healthcare industry. It changed the manner of healthcare delivery dramatically while exposing the lack of preparedness on the part of governments worldwide to adequately tackle a global healthcare emergency. Frontline health workers were involved in managing COVID-19 patients, but patients with other health conditions, especially chronic health conditions, experienced difficulties as their in-clinic visits were postponed or avoided. Moreover, as the outcomes of COVID-19 among patients with comorbidities, especially obesity, heart complications, and diabetes, were worse than those without, these patients were asked to be additionally vigilant. The pandemic also brought a fair share of mental health disorders, including depression, anxiety, and withdrawals, and their management was a challenge due to the lack of face-to-face visits. These interconnected events have made healthcare providers look out for digital health solutions to tackle health crisis. There was a positive trend observed during the COVID-19 outbreak in relation to the adoption of digital health technologies, which increased the efficiency and effectiveness of healthcare operations and service delivery. After the pandemic started, the adoption of DTx applications in various fields accelerated many folds. Additionally, the COVID-19 pandemic increased the adoption of virtual and home care technologies by transforming patient engagement and integrating data across the healthcare landscape.

Digital Therapeutics Market Trends:

At present, there is a rise in the demand for DTx among type 2 diabetes patients to manage the disease and enable them to use the internet of things (IoT)-enabled insulin pumps and other health monitoring systems. This, along with the increasing demand for digital behavior-monitoring treatment to ensure medication adherence and healthy lifestyle changes, represents one of the key factors supporting the growth of the market. In addition, the growing utilization of DTx to reduce the need for more follow-up checkups and relapses compared to traditional treatments is offering a favorable market outlook. Moreover, there is an increase in the prevalence of chronic diseases, such as heart disease, stroke, cancer, obesity, and arthritis. This, coupled with the rising awareness among the masses about personal health and fitness, is propelling the growth of the market. Additionally, the escalating demand for DTx to help doctors manage patient adherence to medical regimens and build an integrated health ecosystem that can enable the seamless transfer of data between different stakeholders, such as payers, providers, and pharmacies, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global digital therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application and end use.

Application Insights:

Diabetes

Obesity

CVD

CNS Disease

Respiratory Diseases

Smoking Cessation

Others

The report has provided a detailed breakup and analysis of the digital therapeutics market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others. According to the report, diabetes represented the largest segment due to the rising prevalence of diabetes, along with the high risk of associated conditions, such as cardiac arrests, kidney failure, and blindness, in diabetic patients. Moreover, the growing integration of DTx with numerous medical devices, such as insulin pumps, glucose blood meters, and wearable gadgets, is positively influencing the market.

End Use Insights:

Patients

Providers

Payers

Employers

Others

A detailed breakup and analysis of the digital therapeutics market based on the end use has also been provided in the report. This includes patients, providers, payers, employers, and others. According to the report, patients accounted for the largest market share due to the rising adoption of DTx among patients for numerous associated benefits pertaining to elective health management at an affordable cost. In addition, the increasing consumer inclination towards patient management systems for improving retention and compliance with post hospitalization follow-up visits is catalyzing the demand for DTx.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for digital therapeutics. Some of the factors driving the North America digital therapeutics market included the growing geriatric population, continuous upgradations in drug approval processes by the Food and Drug Administration (FDA), rising awareness about the benefits of DTx, etc. In addition, the growing utilization of DTx as a standalone therapy or in conjunction with medications, devices, and other therapies to optimize patient care and healthcare outcomes is offering a favorable market outlook.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global digital therapeutics market. Some of the companies covered in the report include:

2Morrow Inc.

Canary Health Inc.

Click Therapeutics Inc.

Mango Health Inc. (TrialCard Incorporated)

Noom Health Inc.

Omada Health Inc.

Pear Therapeutics, Inc.

Propeller Health (ResMed)

Teladoc Health Inc.

Voluntis Inc.

WellDoc Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global digital therapeutics market in 2023?
  • 2. What is the expected growth rate of the global digital therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global digital therapeutics market?
  • 4. What has been the impact of COVID-19 on the global digital therapeutics market?
  • 5. What is the breakup of the global digital therapeutics market based on the application?
  • 6. What is the breakup of the global digital therapeutics market based on the end use?
  • 7. What are the key regions in the global digital therapeutics market?
  • 8. Who are the key players/companies in the global digital therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Digital Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Diabetes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Obesity
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CVD
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CNS Disease
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Respiratory Diseases
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Smoking Cessation
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End Use

  • 7.1 Patients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Providers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Payers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Employers
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 2Morrow Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Canary Health Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Click Therapeutics Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Mango Health Inc. (TrialCard Incorporated)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Noom Health Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Omada Health Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Pear Therapeutics, Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Propeller Health (ResMed)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Teladoc Health Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Voluntis Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 WellDoc Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio